Black rice extract may give your brain a boost
NCT ID NCT06594848
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a supplement made from black rice extract can increase levels of BDNF, a protein important for memory and mood. Researchers will give 12 healthy adults either the supplement or a placebo and measure BDNF in their blood. The goal is to see if this natural extract can support brain health.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 12 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Sep 2024
- Expected to finish
-
Nov 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. The subject is healthy and, in the opinion of the investigator, free of any medical conditions that might affect study measurements. 2. Male or female. 3. Age between 18 - 80 years inclusive. 4. BMI between 21 - 29.9 kg/m2. 5. Female subject of childbearing potential has a negative urine pregnancy test result. 6. Subject agrees to discontinue the use of pre- and/or probiotic and/or polyphenol supplements from 2 days prior to the screening and throughout the study. 7. Subject agrees to consume less than 1/2 cup/day of foods containing AC (such as blueberries, blackberries, bilberries, cherries, grapes, grape juice, pomegranate, raspberries, huckleberries, strawberries) and no more than 1 glass/day of red wine, 3 cups/day of tea or coffee, or 10 g/day of dark chocolate from 2 days prior to the screening and throughout the study. 8. No known allergies to study products or components (rice). 9. Subject is willing to consume a low fat/low flavonoid dinner the evening before study visits. 10. Subject has received a complete COVID-19 vaccine and is at least 6 weeks post-vaccine at the pre-screening visit as verified by shot record or similar documentation. 11. Subject has given voluntary, written, informed consent to participate in the study. Exclusion Criteria: 1. Age \< 18 or \> 80 years. 2. BMI \< 21 or \> 29.9 kg/m2. 3. Vegan, Vegetarian, or other dietary restrictions that would not allow the subject to easily consume a low polyphenol diet leading up to screening and study visits. 4. Current consumption of special diets (e.g. Atkins, keto, paleo, etc.). 5. Current participation or enrollment in another pharmaceutical, weight-loss or nutritional clinical study within the last 30 days. Device trials are exempted. 6. Uncontrolled hypertension defined as diastolic blood pressure ≥ 95 mmHg and/or systolic blood pressure ≥ 160 mmHg. 7. Fasting blood triglycerides \> 150 mg/dL. 8. Self-reported Type 2 Diabetes. 9. Fasting blood glucose \<50 mg/dL or \> 100 mg/dL. 10. Hemoglobin A1c levels ≥ 5.7%. 11. Current smoker or use of tobacco products within the last 180 days. 12. Binge drinking (alcohol intake ≥ 5 alcoholic drinks for males or ≥ 4 alcoholic drinks for females on the same occasion, i.e. at the same time or within a couple of hours of each other). 13. Substance abuse or dependence within the last 60 days. 14. Daily use of anti-inflammatory medications including NSAIDs and aspirin within the last 30 days. 15. Use of laxative medications or other products that promote colon cleansing within the last 30 days. 16. History of restricted diets or use of herbal supplements or medications that interfere with insulin metabolism within the last 30 days. 17. History of stroke, hepatic, gallbladder, kidney, thyroid disease, or cancer. 18. History of immune related disorders or Raynaud's disease. 19. Current clinically significant depression, anxiety, or other psychiatric condition. 20. History of malabsorption or GI tract disorders. 21. History of GI surgeries (e.g. lap band, gastric bypass, etc.). 22. Diarrhea or oral antibiotic intake within the last 30 days. 23. Weight change (\> 5%) within the last 30 days. 24. History of eating disorders such as bulimia, anorexia, or muscle dysmorphia. 25. Allergy or sensitivity to the study products. 26. Subject has not received a complete COVID-19 vaccine or is less than 6 weeks post-vaccine at the screening visit. 27. Any other condition which in the Investigator's opinion might adversely affect the subject's ability to complete the study or its measurements or which might pose significant risk to the subject.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cognition - other are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ragle Human Nutrition Research Center, Academic Surge II
Davis, California, 95616, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can teachers and a phone app ease teen depression?
- Can a Four-Session therapy course ease the mental load on parents of medically complex children?
- Can neighbors help ease depression in older adults?
- Can breathing inside a pyramid ease Diabetes-Related depression?
- Could your smartphone replace the couch? digital therapy put to the test
- Can group prenatal care with social support reduce preterm births?